Seventy-two hours after 5-aza-2′-deoxycytidine (decitabine (DAC)) and trichostatin A (TSA) treatment upregulation of RBBP8 mRNA expression (FC = 11) was demonstrated in RT4 tumor cells. This evidence concerns the gene RBBP8 and neoplasm.